Eqis Capital Management buys $1,902,608 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Eqis Capital Management scooped up 3,307 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 4, 2016. The investment management firm now holds a total of 16,309 shares of Stryker Corporation which is valued at $1,902,608.Stryker Corporation makes up approximately 0.12% of Eqis Capital Management’s portfolio.

Other Hedge Funds, Including , Beacon Financial Group sold out all of its stake in SYK during the most recent quarter. The investment firm sold 2,981 shares of SYK which is valued $347,763.Bath Savings Trust Co boosted its stake in SYK in the latest quarter, The investment management firm added 547 additional shares and now holds a total of 66,267 shares of Stryker Corporation which is valued at $7,730,708. Stryker Corporation makes up approx 2.44% of Bath Savings Trust Co’s portfolio.Lvm Capital Management Ltdmi boosted its stake in SYK in the latest quarter, The investment management firm added 6,809 additional shares and now holds a total of 34,534 shares of Stryker Corporation which is valued at $4,028,736. Stryker Corporation makes up approx 1.27% of Lvm Capital Management Ltdmi’s portfolio.Cullinan Associates Inc reduced its stake in SYK by selling 3,225 shares or 62.93% in the most recent quarter. The Hedge Fund company now holds 1,900 shares of SYK which is valued at $221,654. Stryker Corporation makes up approx 0.02% of Cullinan Associates Inc’s portfolio.

Stryker Corporation closed down -0.19 points or -0.16% at $116.26 with 10,74,069 shares getting traded on Tuesday. Post opening the session at $116.48, the shares hit an intraday low of $115.73 and an intraday high of $116.92 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.